Machine Learning

A breakthrough study validates a low-cost blood test that can detect multiple cancers and liver diseases, poised to transform preventative healthcare.

Broker-dealer AmerX launches an equity research division, integrating its NYSE floor presence with a new focus on physical AI to deliver actionable insights.

A $20M investment in Seedli Capital signals growing institutional belief in tokenized real-world assets. But can the Web3 world meet TradFi's demands?

Dubai-based Surexo surpasses 500,000 users, leveraging AI and a security-first approach to expand its fintech footprint across 30+ countries.

With new backing from Catchment Capital and Stellus, Phoenix-based Vertech is poised to expand its critical role in automating America's industries.

UK biotech Cytospire Therapeutics secures major funding to push its safer, more selective gamma delta T-cell engager into clinical trials for solid tumors.

UK biotech Cytospire secures a major Series A to bring its novel pan-gamma delta T cell engagers, targeting tough solid tumors, into clinical trials.

A new AI tool promises to turn complex financial contracts from a multi-hour headache into minutes of work, reducing risk and unlocking strategic value.

Hungarian pharma giant Gedeon Richter partners with chess legend Judit Polgár, using the game's strategic depth to build brand trust and inspire youth.

The clean energy vehicle company is assembling a top-tier team to develop hydrogen-powered drones, aiming for a slice of the $182 billion UGV market.

Showcasing agentic AI and software-defined controls, SUPCON aims to close the industrial 'execution gap' with a new blueprint for self-optimizing factories.

A top European fertility network is rolling out AI to select embryos, promising higher success rates but sparking debate on the future of data-driven parenthood.

Marking its 10th anniversary, The War Zone rebrands to TWZ, expanding its digital footprint to meet growing demand for in-depth defense journalism.

With Gartner predicting a 25% drop in traditional search, agencies like FOXVISITS are pioneering 'Generative Engine Optimization' to survive the AI shift.

Beyond its first blockbuster, CRISPR Therapeutics reveals a deep pipeline for autoimmune and liver diseases, backed by a strong Q1 balance sheet.

The cloud storage firm topped Q1 estimates and turned a non-GAAP profit, crediting a surge in AI clients drawn to its low-cost, high-performance data platform.

A new report shows a widening gap in ANZ as AI execution, not just adoption, drives major revenue growth, efficiency, and employee satisfaction.

At the elite FiRe 2026 conference, Pattern Computer plans to unveil a 'hallucination-free' AI, promising a new era of scientific discovery and trust.

CTIBIOTECH brings revolutionary 3D human tissue printing to 'Cellicon Valley,' aiming to slash drug failures and accelerate personalized medicine.

New FDA-registered system from Clarapath offers labs a flexible, lower-cost entry into automation, targeting a critical bottleneck in pathology workflows.